FEIM reports revenue growth to $18.9 million for Q3 FY2025. Operating income reached $3.5 million, improving from a loss last year. CEO expresses optimism despite potential external funding risks. R&D expenditures increased to 9% of revenue to enhance competitive capabilities. Backlog remains strong at $73 million despite slight year-on-year decline.
Revenue and operating income growth is a positive indicator. Similar past trends led to sustained price increases.
Continued revenue growth and R&D investment suggest potential for long-term gains.
Strong earnings and future growth potential are highly relevant to investor interest.